menu
    • menu

    Company profile for Akeso

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Akeso, Inc. (9926.HK), established in 2012, is a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide.Since our establishment, the Company has established a comprehensive in-house drug development platform (ACE Platform), encompassing fully integrated drug discovery and development functions, including ta...
    Akeso, Inc. (9926.HK), established in 2012, is a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide.Since our establishment, the Company has established a comprehensive in-house drug development platform (ACE Platform), encompassing fully integrated drug discovery and development functions, including target validation, antibody drug discovery and development, process development, and GMP-compliant commercial-scale manufacturing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AkesoChina Flag
    Country
    Country
    China
    Address
    Address
    No. 6, Shennong Road, Torch Development Zone, Zhongshan City, Guangdong Provin...
    Telephone
    Telephone
    0760-8987 3998
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.akesobio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/akeso-bio/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AkesoInc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ivonescimab + Chemo Shows Efficacy in TNBC at ESMO IO 2025
    Ivonescimab + Chemo Shows Efficacy in TNBC at ESMO IO 2025

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/updated-efficacy-data-of-ivonescimab-combined-with-chemotherapy-as-first-line-treatment-for-tnbc-presented-at-esmo-io-2025-302638641.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share
    Phase 2 Cadonilimab Neoadjuvant Data in Gastric Cancer
    Phase 2 Cadonilimab Neoadjuvant Data in Gastric Cancer

    09 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phase-ii-data-of-cadonilimab-regimen-as-neoadjuvant-therapy-for-resectable-gastric-cancer-presented-at-esmo-asia-2025-302636294.html

    PR NEWSWIRE
    09 Dec 2025
    Share Share
    Akeso Five Innovative Drugs Included in China NRDL
    Akeso Five Innovative Drugs Included in China NRDL

    07 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/all-approved-indications-of-five-akesos-innovative-drugs-included-in-chinas-latest-nrdl-featuring-two-first-in-class-bispecifics-with-new-first-line-indications-and-three-newly-negotiated-drugs-302634722.html

    PR NEWSWIRE
    07 Dec 2025
    Share Share
    China Approves Akeso's AB/BBB Bispecific for Alzheimer's Trials
    China Approves Akeso's AB/BBB Bispecific for Alzheimer's Trials

    17 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/akesos-bispecific-antibody-targeting-a-and-bbb-expressed-receptor-approved-for-alzheimers-disease-clinical-trials-in-china-302616507.html

    PR NEWSWIRE
    17 Nov 2025
    Share Share
    Akeso Initiates Phase I Trial For AK154 mRNA Vaccine
    Akeso Initiates Phase I Trial For AK154 mRNA Vaccine

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/akeso-announces-first-patient-dosed-in-phase-i-trial-of-personalized-mrna-vaccine-ak154-as-monotherapy-or-in-combination-with-cadonilimab-or-ivonescimab-for-adjuvant-treatment-of-pancreatic-cancer-302610059.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share
    Ivonescimab HARMONi-A Final OS Data Presented With HR=0.74
    Ivonescimab HARMONi-A Final OS Data Presented With HR=0.74

    07 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ivonescimab-harmoni-a-study-final-os-analysis-results-presented-at-sitc-2025-with-os-hr0-74--302608764.html

    PR NEWSWIRE
    07 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search